ELTROMBOPAG (ELTROMBOPAG OLAMINE) — all Canadian products
8 DINs
6 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is ELTROMBOPAG (ELTROMBOPAG OLAMINE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02506769 | APO-ELTROMBOPAG | APOTEX INC | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 50 MG | Marketed | |
| 02506742 | APO-ELTROMBOPAG | APOTEX INC | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 25 MG | Marketed | |
| 02361825 | REVOLADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 25 MG | Marketed | |
| 02361833 | REVOLADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 50 MG | Marketed | |
| 02551721 | TEVA-ELTROMBOPAG | TEVA CANADA LIMITED | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 25 MG | Approved | |
| 02551748 | TEVA-ELTROMBOPAG | TEVA CANADA LIMITED | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 50 MG | Approved | |
| 02461382 | REVOLADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 12.5 MG | Cancelled Pre Market | |
| 02423049 | REVOLADE | NOVARTIS PHARMACEUTICALS CANADA INC | Tablet | Oral | ELTROMBOPAG (ELTROMBOPAG OLAMINE) 75 MG | Cancelled Pre Market |
Browse other molecules: